Research ArticleDRUG TESTING

Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics

See allHide authors and affiliations

Science Translational Medicine  19 Jun 2019:
Vol. 11, Issue 497, eaav1386
DOI: 10.1126/scitranslmed.aav1386

Article Information

vol. 11 no. 497

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication August 17, 2018
  • Resubmitted November 16, 2018
  • Accepted for publication May 17, 2019
  • .

Author Information

  1. Christopher W. McAleer1,*,
  2. Christopher J. Long1,*,
  3. Daniel Elbrecht1,
  4. Trevor Sasserath1,
  5. L. Richard Bridges1,
  6. John W. Rumsey1,
  7. Candace Martin2,
  8. Mark Schnepper2,
  9. Ying Wang2,
  10. Franz Schuler3,
  11. Adrian B. Roth3,
  12. Christoph Funk3,
  13. Michael L. Shuler1 and
  14. James J. Hickman1,2,
  1. 1Hesperos Inc., 3259 Progress Drive, Room 158, Orlando, FL 32826, USA.
  2. 2NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA.
  3. 3Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  1. Corresponding author. Email: jhickman{at}hesperosinc.com
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: June 2019 to December 2019

AbstractFullPdf
Jun 201962211277590
Jul 20191286310253
Aug 2019362142148
Sep 2019430117112
Oct 20193707165
Nov 20193897161
Dec 20191943037

Stay Connected to
   Science Translational Medicine